ГоловнаАрхiв номерiв2021Том 29, випуск 2 (107)Психопатологічні наслідки COVID-19: можливості запобігання та лікування
Назва статтi Психопатологічні наслідки COVID-19: можливості запобігання та лікування
Автори Марута Наталія Олександрівна
Федченко Вікторія Юріївна
З рубрики НА ДОПОМОГУ ПРАКТИЧНОМУ ЛІКАРЮ
Рiк 2021 Номер журналу Том 29, випуск 2 (107) Сторінки 76-82
Тип статті Наукова стаття Індекс УДК 616-036.21:371.711-08 Індекс ББК -
Анотацiя DOI: https://doi.org/10.36927/2079-0325-V29-is2-2021-13 Під час пандемії COVID-19 створюються умови для погіршення психічного здоров’я широкого кола осіб з груп ризику. Маніфестація або загострення психічних захворювань сприяє поширенню COVID-19 і асоціюються з частим розвитком соматичних ускладнень і несприятливим прогнозом. Під час проведення психофармакотерапії у пацієнтів з COVID-19 треба враховувати її вплив на функцію дихання, імовірні побічні ефекти і міжлікарські взаємодії. Препаратом, що може бути рекомендований для лікування депресивної та тривожно-депресивної симптоматики при COVID-19, є представник сучасного класу антидепресантів, мультимодальних модуляторів серотонінової системи — тразодон.
Ключовi слова коронавірусна хвороба COVID-19, психічні порушення, депресивні розлади, терапія, тразодон
Доступ до повної статтi pdf Скачати
Перелiк
використаної
лiтератури		 1. World Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. URL: http://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 (Accessed on February 12, 2020). 2. Campion J., Javed A., Marmot M., Valsraj K. The need for a public mental health approach to COVID-19 // World Social Psychiatry. 2020; 2: 77—83. DOI: 10.4103/WSP.WSP_48_20. 3. The Psychological Impact of Quarantine and How to Reduce It: Rapid Review of the Evidence / Brooks S. K., Webster R. K., Smith L. E. [et al.] // The Lancet. 2020; 395: 912—920. DOI: https://doi.org/10.1016/S0140-6736(20)30460-8 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30460-8/fulltext. 4. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China / Wang C., Pan R., Wan X. [et al.] // Int J Environ Res Public Health. 2020 Mar 6; 17(5): 1729. DOI: 10.3390/ijerph17051729. 5. Morens D. M., Fauci A. S. The 1918 influenza pandemic: insights for the 21st century // J. Infect. Dis. 2007; 195, 1018—1028. DOI: 10.1086/511989. 6. Lu H., Stratton C. W., Tang Y. W. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle // J. Med. Virol. 2020; 92, 401—402. DOI: 10.1002/jmv.25678. 7. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China / Hui D. S., Azhar E. I., Madani T. A. [et al.] // Int J. Infect. Dis. 2020; 91: 264—266. DOI: 10.1016/j.ijid.2020.01.009. 8. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 / Gorbalenya A. E., Baker S. C., Banic R. S. [et al.] // Nat. Microbiol. 2020; 5, 536—544. 9. The respiratory control mechanisms in the brainstem and spinal cord: integrative views of the neuroanatomy and neurophysiology / Keiko Ikeda, Kiyoshi Kawakami, Hiroshi Onimaru [et al.] // J. Physiol. Sci. 2017; 67, 45—62. DOI: 10.1007/s12576-016-0475-y. 10. Benarroch E. E. Brainstem respiratory chemosensitivity: new insights and clinical implications // Neurology. 2007; 68, 2140—2143. DOI: https://doi.org/10.1212/01.wnl.0000266560.60371.98. 11. Aziz, M., Fatima, R., Assaly, R. Elevated interleukin‐6 and severe COVID‐19: a meta‐analysis// J. Med. Virol. 2020 Nov; 92 (11): 2283—2285. DOI: 10.1002/jmv.25948. 12. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity / Lindqvist D., Janelidze Sh., Hagell P. [et al.] // Biol. Psychiatry 2009; 66, 287—292. DOI: 10.1016/j.biopsych.2009.01.030. 13. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder / Sasayama D., Hattori K., Wakabayashi Ch. [et al.] // J. Psychiatr. 2013; Res 47, 401—406. DOI: 10.1016/j.jpsychires.2012.12.001. 14. Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample / Kern S., Skoog I., Börjesson-Hanson A. [et al.] // Brain Behav. Immun. 2014; 41, 55—58. DOI: 10.1016/j.bbi.2014.05.006. 15. Castro VM, Perlis RH. Electronic Health Record Documentation of Psychiatric Assessments in Massachusetts Emergency Department and Outpatient Settings During the Coronavirus Disease 2019 (COVID-19) Pandemic // JAMA Netw Open 2020; 3:e2011346. 16. Wilkinson E. How mental health services are adapting to provide care in the pandemic // BMJ 2020; 369:m2106. DOI: 10.1136/bmj.m2106. 17. Xiang Y. T., Jin Y., Cheung T. Joint International Collaboration to Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic // JAMA Psychiatry 2020. DOI: 10.1001/jamapsychiatry.2020.1057 18. Psychological distress, coping behaviors, and preferences for support among New York healthcare workers during the COVID-19 pandemic / Shechter A., Diaz F., Moise N. [et al.] // Gen Hosp Psychiatry. 2020; 66:1. DOI: 10.1016/j.genhosppsych.2020.06.007 19. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019 / Lai J., Ma S., Wang Y. [et al.] // JAMA Netw Open. 2020; 3: e203976. DOI: 10.1001/jamanetworkopen.2020.3976. 20. Mental Health Outcomes Among Frontline and Second-Line Health Care Workers During the Coronavirus Disease 2019 (COVID-19) Pandemic in Italy / Rossi R., Socci V., Pacitti F. [et al.] // JAMA Netw Open. 2020; 3: e2010185. DOI: 10.1001/jamanetworkopen.2020.10185. 21. Potloc and Canadian Public Health Association. Perception of Canadian health workers around the COVID-19 outbreak. URL: https://potloc.com/blog/en/potloc-study-canadian-health-workers-insights-front-lines-covid-19-pandemic/ (Accessed on July 05, 2020). 22. Psychological Impact of the COVID-19 Pandemic on Health Care Workers in Singapore / Tan BYQ, Chew NWS, Lee GKH [et al.] // Ann Intern Med. 2020; 173: 317. DOI: 10.7326/M20-1083. 23. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science / Holmes E. A, O’Connor R. C., Perry V. H. [et al.] // Lancet Psychiatry. 2020; 7: 547. DOI: https://doi.org/10.1016/S2215-0366(20)30168-1. 24. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China / Wang C., Pan R., Wan X. [et al.] // Int J Environ Res Public Health. 2020; 17. DOI: 10.3390/ijerph17051729. 25. Prevalence and correlates of PTSD and depressive symptoms one month after the outbreak of the COVID-19 epidemic in a sample of home-quarantined Chinese university students / Tang W, Hu T, Hu B,. [et al.] // J Affect Disord. 2020; 274:1. DOI: 10.1016/j.jad.2020.05.009 26. Psychological symptoms of ordinary Chinese citizens based on SCL-90 during the level I emergency response to COVID-19 Tian F, Li H, Tian S. [et al.] // Psychiatry Res. 2020; 288: 112992. DOI: 10.1016/j.psychres.2020.112992. 27. American Psychiatric Association. New poll: COVID-19 impacting mental well-being: Americans feeling anxious, especially for loved ones; older adults are less anxious. 2020. URL: https://www.psychiatry.org/newsroom/news-releases/new-poll-covid-19-impacting-mental-well-being-americans-feeling-anxious-especially-for-loved-ones-older-adults-are-less-anxious (Accessed on June 11, 2020). 28. McGinty E. E., Presskreischer R., Han H., Barry C. L. Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020 // JAMA. 2020; 324:93. DOI: 10.1001/jama.2020.9740. 29. Pfefferbaum B., North C. S. Mental Health and the Covid-19 Pandemic // N Engl J Med. 2020; 383:510. DOI: 10.1056/NEJMp2008017. 30. Reger M. A., Stanley I. H., Joiner T. E. Suicide Mortality and Coronavirus Disease 2019-A Perfect Storm? JAMA Psychiatry 2020; 77 (11): 1093—1094. DOI: 10.1001/jamapsychiatry.2020.1060. 31. The psychological impact of quarantine and how to reduce it: rapid review of the evidence / Brooks S. K., Webster R. K., Smith L. E. [et al.] // Lancet. 2020; 395: 912. DOI: https://doi.org/10.1016/S0140-6736(20)30460-8. 32. Galea S., Merchant R. M., Lurie N. The Mental Health Consequences of COVID-19 and Physical Distancing: The Need for Prevention and Early Intervention // JAMA Intern Med. 2020; 180: 817. DOI: 10.1001/jamainternmed.2020.1562. 33. Mental Health Response to the COVID-19 Outbreak in China / Zhou J., Liu L., Xue P. [et al.] // Am J Psychiatry 2020; 177:574. DOI: 10.1176/appi.ajp.2020.20030304. 34. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic / Rogers J. P., Chesney E., Oliver D. [et al.] // Lancet Psychiatry. 2020; 7: 611. DOI: https://doi.org/10.1016/S2215-0366(20)30203-0. 35. Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis / Kisely S., Warren N., McMahon L. [et al.] // BMJ. 2020; 369: m1642. DOI: 10.1136/bmj.m1642. 36. Sommer I. E., Bakker P. R. What can psychiatrists learn from SARS and MERS outbreaks? // Lancet Psychiatry. 2020; 7: 565. DOI: 10.1016/S2215-0366(20)30219-4. 37. Stam H. J., Stucki G., Bickenbach J. Covid-19 and Post Intensive Care Syndrome: A Call for Action // J Rehabil Med. 2020; 52: jrm00044. DOI: 10.2340/16501977-2677. 38. Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis / Nikayin S., Rabiee A., Hashem M. D. [et al.] // Gen Hosp Psychiatry. 2016; 43: 23. DOI: 10.1016/j.genhosppsych.2016.08.005. 39. Depressive Symptoms After Critical Illness: A Systematic Review and Meta-Analysis / Rabiee A., Nikayin S., Hashem M. D., [et al.] // Crit Care Med. 2016; 44: 1744. DOI: 10.1097/CCM.0000000000001811. 40. Posttraumatic stress disorder in critical illness survivors: a metaanalysis / Parker A. M., Sricharoenchai T., Raparla S. [et al.] // Crit Care Med 2015; 43:1121. DOI: 10.1097/CCM.0000000000000882 41. Anxiety, Depression and Post Traumatic Stress Disorder after critical illness: a UK-wide prospective cohort study / Hatch R., Young D., Barber V. [et al.] // Crit Care. 2018; 22: 310. DOI: 10.1186/s13054-018-2223-6. 42. Comparison of Simulated Treatment and Cost-effectiveness of a Stepped Care Case-Finding Intervention vs Usual Care for Posttraumatic Stress Disorder After a Natural Disaster / Cohen G. H., Tamrakar S., Lowe S. [et al.] // JAMA Psychiatry. 2017; 74:1251. DOI: 10.1001/jamapsychiatry.2017.3037. 43. Mitigating the psychological effects of social isolation during the covid-19 pandemic / Razai M. S., Oakeshott P., Kankam H. [et al.] // BMJ. 2020; 369: m1904. DOI: https://doi.org/10.1136/bmj.m1904. 44. Zhang K., Zhou X., Liu H., Hashimoto K. Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders // Br J Psychiatry. 2020; 217: 351. DOI: 10.1192/bjp.2020.84. 45. Rediscovering trazodone for the treatment of major depressive disorder / A. Fagiolini, A. Comandini, M. C. Dell'Osso, S. Kasper // CNS Drugs. 2012; 26: 1033—49. DOI: 10.1007/s40263-012-0010-5. 46. Stahl S. M. Mechanism of action of trazodone: a multifunctional drug // CNS Spectr. 2009; 14: 536—46. DOI: 10.1017/s1092852900024020. 47. Karhu D., Groenewoud G., Potgieter M. A., Mould D. R. Dose proportionality of once-daily trazodone extended-release caplets under fasting conditions // J Clin Pharmacol. 2010; 50: 1438—49. DOI: 10.1177/0091270009360979. 48 Frecska E. Trazodone — it’s multifunctional mechanism of action and clinical use // Neuropsychofarmacol Hung. 2010; 12: 477—82. 49. Смулевич А. Б. Депрессии при соматических и психических заболеваниях / А. Б. Смулевич. М.: Медицинское информационное агентство, 2003: 209 с. 50. Busner J. The clinical global impressions scale: applying a research tool in clinical practice // Psychiatry (Edgmont). 2007; 4 (7): 28—37.